Author's posts
55% of total collections at ASCs come from commercial payers
Commercial payers account for 55 percent of total collections at ASCs, according to VMG Health’s “Multi-Specialty ASC Benchmarking Study” for 2022.
Quincy Medical Group is 1st freestanding ASC in Illinois to perform cardiac catheterization
Quincy (Ill.) Medical Group Surgery Center is the first freestanding ASC in Illinois to perform a cardiac catheterization, according to a March 7 news release shared with Becker’s.
How payer mix for ASCs stacks up
Commercial payers account for an average of 44 percent of total cases in ASCs, according to VMG Health’s “Multi-Specialty ASC Benchmarking Study” for 2022.
1 in 5 physicians are depressed, survey says
Twenty-one percent of physicians reported being depressed in 2022, according to Medscape’s “Physician Suicide Report 2022” published March 4.
120,000-square-foot office building to be converted to lab
A 120,000-square-foot office building in Andover, Mass., has been acquired and will be converted into a lab, according to a March 3 Boston Real Estate Times article.
Ophthalmology property sold for $1.34M
A 5,096-square-foot medical office property housing Dearborn (Mich.) Ophthalmology was sold for $1.34 million, according to a March 4 REjournals article.
Massachusetts ASC nurse agrees to plea deal in fentanyl-tampering case
A nurse from an outpatient vascular surgery center in Berkley, Mass., has agreed to plead guilty in federal court to tampering with a consumer product, fentanyl intended for a patient, the Justice Department said March 4.
10 administrators to know
Here are 10 ASC administrators to know:
Companies using noncompetes may be criminally prosecuted, Justice Department signals
The Justice Department has opened the door to criminally prosecute companies that have noncompete agreements it deems too restrictive and in violation of antitrust laws, according to a report in JDSupra, a legal analysis company.
How oral microbiome therapy could change C. diff treatment
Paul Feuerstadt, MD, and Louis Korman, MD, spoke with Becker’s about how a study published in The New England Journal of Medicine could change how the gastroenterology industry treats Clostridioides difficile.
